Gilead’s Livdelzi wins FDA approval, can challenge Ocaliva dominance in primary biliary cholangitis market Read more
Madrigal Pharmaceuticals poised for market dominance with Rezdiffra’s first full quarter success and growing MASH market potential Read more
Obesity drug tirzepatide approval in China strengthens market position amid GLP-1 agonist competition: GlobalData Read more
Rubicon Research files for IPO with SEBI, Targets ₹10,850 Million to drive growth and innovation Read more